Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
0.4049
-0.0487 (-10.74%)
At close: Jun 9, 2026, 4:00 PM EDT
0.4097
+0.0048 (1.19%)
Pre-market: Jun 10, 2026, 5:05 AM EDT
Heron Therapeutics Employees
Heron Therapeutics had 128 employees as of December 31, 2025. The number of employees increased by 6 or 4.92% compared to the previous year.
Employees
128
Change (1Y)
6
Growth (1Y)
4.92%
Revenue / Employee
$1,177,438
Profits / Employee
-$241,727
Market Cap
76.64M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 128 | 6 | 4.92% |
| Dec 31, 2024 | 122 | -4 | -3.17% |
| Dec 31, 2023 | 126 | -77 | -37.93% |
| Dec 31, 2022 | 203 | -99 | -32.78% |
| Dec 31, 2021 | 302 | 79 | 35.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Rani Therapeutics Holdings | 71 |
| Aardvark Therapeutics | 40 |
| eXoZymes | 32 |
| NeurAxis | 24 |
| MAIA Biotechnology | 13 |
| ProMIS Neurosciences | 11 |
| Annovis Bio | 7 |
HRTX News
- 6 days ago - Heron Therapeutics price target lowered to $2 from $4 at H.C. Wainwright - TheFly
- 7 days ago - Heron Therapeutics downgraded at Needham after Cinvanti patents invalidated - TheFly
- 7 days ago - Heron Therapeutics downgraded to Hold from Buy at Needham - TheFly
- 7 days ago - Heron announces U.S. district court decision regarding Cinvanti patents - TheFly
- 7 days ago - U.S. District Court Issues Decision Regarding CINVANTI® Patents - GlobeNewsWire
- 4 weeks ago - Heron Therapeutics price target lowered to $4 from $6 at H.C. Wainwright - TheFly
- 4 weeks ago - Heron Therapeutics reports Q1 EPS (4c), consensus (2c) - TheFly
- 4 weeks ago - Heron Therapeutics backs FY26 revenue view $173M-$183M, consensus $174.73M - TheFly